Disorders A - Z:   A    B   C    D    E    F    G    H    I    J    K    L    M    N    O    P    Q    R    S    T    U    V    W    X    Y    Z

Skip secondary menu

NINDS Specific Program/Budget Information


Limited Amount of Award

Applicants must follow the language and guidelines (including budget) in the specific program announcement they applied to. Certain Program Announcements may have more limited budget guidelines than listed below. Applicants are encouraged to contact program staff with any budget questions prior to submitting an application.

For budgetary, administrative, or programmatic reasons, NINDS may decrease the length of an award and/or the budget recommended by a review committee, or not fund an application. According to statutory guidelines, total funding support (direct costs, indirect costs, fee) normally may not exceed $150,000 for Phase I awards and $1,000,000 for Phase II awards. With appropriate justification from the applicant, Congress will allow awards to exceed these amounts by up to 50%. Applicants considering a requested budget greater than $225,000 for Phase I and $1,500,000 for Phase II (total funding support) are strongly encouraged to contact Stephanie Fertig (fertigs@ninds.nih.gov) before submitting an application.


NIH has received a waiver from SBA to exceed the hard cap for specific topics. A list of the NINDS topics can be found here. Generally, NINDS does not fund Phase I applications greater than $700,000 total funding support, with no more than $500,000 total cost in any year or project periods greater than 2 years. In addition, the NINDS does not generally fund Phase II applications greater than $3,000,000 total funding support, with no more than $1,500,000 total cost in any year, or project periods greater than 3 years. Again, applicants considering a requested budget greater than these limits are strongly encouraged to contact program staff before submitting an application. For details see PHS 2014-02.

Phase IIB Competing Renewal Awards

In addition to the traditional Phase I and II applications, NINDS accepts Phase IIB SBIR/STTR Competing Renewal applications through specific opportunities that focus on the commercialization of SBIR and STTR developed technologies. These opportunities can be found on the NIH SBIR web page.

Clinical Trials

The NINDS is committed to identifying effective treatments for neurological disorders by supporting well-executed clinical trials. NINDS will not accept unsolicited SBIR/STTR applications that include clinical trials under the Omnibus solicitation. A clinical trial is a prospective biomedical or behavioral research study of human subjects designed to answer specific questions about the safety, tolerability, efficacy and/or effectiveness of pharmacologic, behavioral, biologic, surgical, or device interventions. This policy does not apply to (1) exploratory IND studies as defined by the FDA or (2) early feasibility studies of devices as defined by the FDA.

NINDS accepts and supports SBIR and STTR clinical trial applications through specific funding opportunities, which can be found on the NINDS SBIR web page.  Other human subjects research can also be submitted through the Omnibus solicitation. NINDS may decline funding of any application that includes human subjects for programmatic or administrative reasons. SBIR applicants considering projects involving human subjects research are strongly encouraged to contact Stephanie Fertig or Joanne Odenkirchen (contact information provided below) within the NINDS Office of Clinical Research.

Program Contact

Stephanie Fertig, M.B.A.
Small Business Program
National Institute of Neurological Disorders and Stroke
National Institutes of Health
NSC, Room 2228
6001 Executive Blvd.
Bethesda, MD 20892-9521
(Courier:  Rockville, MD 20852)
Tel: (301) 496-1779
Fax: (301) 480-1080

Clinical Trials Contact

Joanne C Odenkirchen, MPH
Office of Clinical Research
National Institute of Neurological Disorders and Stroke
National Institutes of Health
NSC, Room 2178
6001 Executive Blvd.
Bethesda, MD 20892-9521
(Courier:  Rockville, MD 20852)
Tel: (301) 496-3104
Fax: (301) 480-1080

Last updated November 3, 2014